162 related articles for article (PubMed ID: 15198641)
1. Early treatment during a primary malaria infection modifies the development of cross immunity.
Legorreta-Herrera M; Ventura-Ayala ML; Licona-Chávez RN; Soto-Cruz I; Hernández-Clemente FF
Parasite Immunol; 2004 Jan; 26(1):7-17. PubMed ID: 15198641
[TBL] [Abstract][Full Text] [Related]
2. Study on protective immunity against infection of Plasmodium yoelii 17XL in DBA/2 mice.
Zheng W; Liu J; Meng DY; Hu XF; Cao YM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):14-8. PubMed ID: 16866134
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
4. Parasitaemia levels in Plasmodium chabaudi infected-mice modify IFN-gamma and IL-10 expression after a homologous or heterologous challenge.
Aguilar-Medina M; Ramos-Payán R; Arámbula-Meraz E; Sánchez-Torres L; Favila-Castillo L
Parasite Immunol; 2010 Apr; 32(4):267-74. PubMed ID: 20398227
[TBL] [Abstract][Full Text] [Related]
5. Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections.
Smith EC; Taylor-Robinson AW
Parasitol Res; 2003 Jan; 89(1):26-33. PubMed ID: 12474040
[TBL] [Abstract][Full Text] [Related]
6. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
7. Development of antimalaria immunity in mice lacking IFN-gamma receptor.
Tsuji M; Miyahira Y; Nussenzweig RS; Aguet M; Reichel M; Zavala F
J Immunol; 1995 May; 154(10):5338-44. PubMed ID: 7537305
[TBL] [Abstract][Full Text] [Related]
8. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice.
von der Weid T; Kopf M; Köhler G; Langhorne J
Eur J Immunol; 1994 Oct; 24(10):2285-93. PubMed ID: 7925557
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice.
Ma SH; Zheng L; Liu YJ; Guo SY; Feng H; Chen G; Li DM; Wang JC; Cao YM
Exp Parasitol; 2007 Jul; 116(3):266-72. PubMed ID: 17336298
[TBL] [Abstract][Full Text] [Related]
10. The time course of selected malarial infections in cytokine-deficient mice.
van der Heyde HC; Pepper B; Batchelder J; Cigel F; Weidanz WP
Exp Parasitol; 1997 Feb; 85(2):206-13. PubMed ID: 9030670
[TBL] [Abstract][Full Text] [Related]
11. Possible modulation by male sex hormone of Th1/Th2 function in protection against Plasmodium chabaudi chabaudi AS infection in mice.
Zhang Z; Chen L; Saito S; Kanagawa O; Sendo F
Exp Parasitol; 2000 Nov; 96(3):121-9. PubMed ID: 11162362
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium chabaudi adami: interferon-gamma but not IL-2 is essential for the expression of cell-mediated immunity against blood-stage parasites in mice.
Batchelder JM; Burns JM; Cigel FK; Lieberg H; Manning DD; Pepper BJ; Yañez DM; van der Heyde H; Weidanz WP
Exp Parasitol; 2003 Oct; 105(2):159-66. PubMed ID: 14969693
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect.
Pouniotis DS; Proudfoot O; Bogdanoska V; Apostolopoulos V; Fifis T; Plebanski M
Infect Immun; 2004 Sep; 72(9):5331-9. PubMed ID: 15322030
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection.
Linke A; Kühn R; Müller W; Honarvar N; Li C; Langhorne J
Exp Parasitol; 1996 Nov; 84(2):253-63. PubMed ID: 8932775
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immune responses to single or mixed infections with P. yoelii 17XL and P. chabaudi AS in different strains of mice.
Chen G; Feng H; Liu J; Qi ZM; Wu Y; Guo SY; Li DM; Wang JC; Cao YM
Parasitol Int; 2010 Sep; 59(3):400-6. PubMed ID: 20609420
[TBL] [Abstract][Full Text] [Related]
16. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection.
Couper KN; Phillips RS; Brombacher F; Alexander J
Parasite Immunol; 2005 May; 27(5):171-80. PubMed ID: 15987340
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium chabaudi chabaudi: effect of low parasitemias on immunity in CB6F1 mice.
Favila-Castillo L; Monroy-Ostria A; Garcia-Tapia D
Exp Parasitol; 1999 May; 92(1):73-80. PubMed ID: 10329368
[TBL] [Abstract][Full Text] [Related]
18. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites.
Scorza T; Grubb K; Cambos M; Santamaria C; Tshikudi Malu D; Spithill TW
Int J Parasitol; 2008 Jun; 38(7):819-27. PubMed ID: 18062974
[TBL] [Abstract][Full Text] [Related]
20. Endogenous galectin-3 controls experimental malaria in a species-specific manner.
Toscano MA; Tongren JE; de Souza JB; Liu FT; Riley EM; Rabinovich GA
Parasite Immunol; 2012 Jul; 34(7):383-7. PubMed ID: 22486577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
